PolicyMonday, March 16, 2026Mongabay
Pharmaceutical companies move away from horseshoe crab biomedical testing
Pharmaceutical companies are shifting away from using horseshoe crab blood in biomedical testing, a practice that has raised concerns over the sustainability of horseshoe crab populations, which have significantly declined in recent years. This change could lead to more sustainable alternatives in the industry while also helping to preserve marine biodiversity.
